Riskpilot← Back to searchSign inGet full accessIlokos Oy
OYDissolvedY-tunnus 2897676-9Itäinen Pitkäkatu 54-B34Medical specialists activities · NACE 8622Est. 2018— employees
Revenue 2025
EUR 439K
-3% vs 2024
EBITDA margin
58.8%
-62% vs 2024
Equity ratio
99.4%
Financial strength
Net profit 2025
EUR 209K
-7% vs 2024
| Revenue | EUR 439K | -3% |
| EBITDA | EUR 258K | -62% |
| Net profit | EUR 209K | -7% |
| Total assets | EUR 1,1M | +12% |
| Equity | EUR 1,1M | +14% |
| Employees | — | — |
Legal name
Ilokos Oy
Y-tunnus number
2897676-9
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
23. helmikuuta 2018
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-11-30
Financial year
January – December
Company purpose
Erikoislääkäripalvelujen tuottaminen potilaille, alan koulutus- ja konsultointipalvelujen tuottaminen, luennointi, valmennus sekä kustannustoiminta. Erilaisten terveydenhoitovälineiden ja -tarvikkeiden maahantuonti, tukku- ja vähittäiskauppa. Yhtiö voi omistaa, hallita ja vuokrata sekä välittää kiinteistöjä, liike- ja asuinhuoneistoja sekä kulkuneuvoja. Yhtiö voi harjoittaa arvopaperikauppaa.
Address
Itäinen Pitkäkatu 54-B34
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 349 | 333 | 405 | 455 | 439 |
| Staff expenses | −81 | −58 | −60 | 70 | −68 |
| EBITDA | 185 | 221 | 258 | 676 | 258 |
| Depreciation & amort. | −7 | −5 | −4 | 3 | −2 |
| EBIT | 178 | 216 | 254 | 275 | 256 |
| Net financials | −0 | −19 | −5 | 6 | 15 |
| Profit before tax | 178 | 196 | 249 | 279 | 261 |
| Tax | 36 | 43 | 51 | 55 | −52 |
| Net profit | 142 | 153 | 197 | 224 | 209 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 556 | 668 | 825 | 982 | 1 102 |
| Equity | 553 | 661 | 805 | 964 | 1 096 |
| Long-term debt | 2 | 2 | 0 | — | — |
| Short-term debt | 1 | 5 | 20 | 18 | 6 |
| Total debt | 3 | 7 | 20 | 18 | 6 |
EBITDA margin
58.8%
This company
15.8%
Market median
+272% vs market
20212025
Equity ratio
99.4%
This company
38.2%
Market median
+160% vs market
20212025
Return on equity
19.1%
This company
18.4%
Market median
+4% vs market
20212025
Net profit margin
47.7%
This company
8.1%
Market median
+489% vs market
20212025
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-12-01 – 2025-11-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-12-01 – 2024-11-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-12-01 – 2023-11-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-12-01 – 2022-11-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-12-01 – 2021-11-30
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
II Chief Executive Officer | Chief Executive Officer | 2018 |
EV Deputy Member | Deputy Member | 2018 |
JA | Audit | 2021 |
PR Deputy auditor | Deputy auditor | 2021 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ilokos Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ilona Inkeri Koski | Chief Executive Officer | 0 companies |
| Elina Vilhelmiina Koski | Deputy Member | 0 companies |
| Jose Adam Juhani Kautonen | Audit | 0 companies |
| Petteri Raine Lagus | Deputy auditor | 0 companies |